%0 Journal Article
%T 应用高流量吸氧与BiPAP对AECOPD治疗的研究现状<br>Research Current Status of High Flow Oxygen Inhalation and BiPAP in Treatment with AECOPD
%A 杨瑞雪
%A 马德花
%J Journal of Clinical Personalized Medicine
%P 212-216
%@ 2334-3443
%D 2024
%I Hans Publishing
%R 10.12677/jcpm.2024.32031
%X 慢性阻塞性肺疾病(Chronic Obstructive Pulmonary Disease, COPD)是一种主要表现为气流受限的慢性呼吸系统疾病，其主要原因包括长时间的吸烟、空气污染和职业暴露等多种因素。该疾病的主要表现为咳嗽、咳痰和呼吸不畅等症状，严重情况下可能会降低患者的生活品质。在最近的几年中，慢性阻塞性肺病的患病率和致死率都在不断攀升。急性加重慢性阻塞性肺疾病(Acute Exacerbation of Chronic Obstructive Pulmonary Disease, AECOPD)不仅是COPD患者疾病恶化的主导因素，也是导致COPD患者残疾和死亡率上升的关键因素。它严重地影响了病人的生活质量，同时也给病人家庭，医疗系统及社会都造成了巨大的经济负担。目前AECOPD治疗方法以提高患者氧合为主，因此本文主要就目前AECOPD两种氧疗方法做出了总结，并力求为未来探讨AECOPD的治疗方法提供一些基础资料与借鉴。<br />
Chronic Obstructive Pulmonary Disease (COPD) is a chronic respiratory disease primarily characterized by limited airflow, with major causes including prolonged smoking, air pollution, and occupational exposure. The main symptoms of this disease are coughing, expectoration, and difficulty breathing, which can severely reduce the quality of life of patients in serious cases. In recent years, the prevalence and mortality rate of chronic obstructive pulmonary disease have been continuously rising. Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is not only the leading factor in the deterioration of COPD patients but also a key factor contributing to the increase in disability and mortality rates among COPD patients. It severely affects the quality of life of patients and also imposes a significant economic burden on patients’ families, the healthcare system, and society. Currently, the treatment methods for AECOPD (Acute Exacerbation of Chronic Obstructive Pulmonary Disease) primarily focus on improving patient oxygenation. Hence, this article summarizes the current two oxygen therapy methods for AECOPD and strives to provide some foundational data and references for future discussions on treatment approaches for AECOPD.
%K 慢性阻塞性肺疾病，急性加重期，经鼻高流量吸氧，BiPAP，治疗<br>Chronic Obstructive Pulmonary Disease
%K Acute Exacerbation
%K High-Flow Nasal Oxygen
%K BiPAP
%K Treatment
%U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=88832